Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Non-Current Liabilities (2017 - 2026)

Organogenesis Holdings has reported Total Non-Current Liabilities over the past 9 years, most recently at $163.6 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 46.51% year-over-year to $163.6 million; the TTM value through Dec 2025 reached $163.6 million, up 46.51%, while the annual FY2025 figure was $163.6 million, 46.51% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $163.6 million at Organogenesis Holdings, up from $121.3 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $202.0 million in Q2 2022 and troughed at $96.9 million in Q2 2025.
  • A 5-year average of $166.7 million and a median of $178.8 million in 2024 define the central range for Total Non-Current Liabilities.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 46.51% in 2025 and fell as far as 45.69% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $200.4 million in 2021, then decreased by 8.88% to $182.6 million in 2022, then decreased by 1.32% to $180.1 million in 2023, then tumbled by 38.01% to $111.7 million in 2024, then skyrocketed by 46.51% to $163.6 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for ORGO at $163.6 million in Q4 2025, $121.3 million in Q3 2025, and $96.9 million in Q2 2025.